Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars. [electronic resource] by
- Desai, Rishi J
- Kim, Seoyoung C
- Curtis, Jeffrey R
- Bosco, Jaclyn L F
- Eichelberger, Bernadette
- Barr, Charles E
- Lockhart, Catherine M
- Bradbury, Brian D
- Clewell, Jerry
- Cohen, Hillel P
- Gagne, Joshua J
Producer: 20210426
In:
Pharmacoepidemiology and drug safety vol. 29
Availability: No items available.
|
|
12.
|
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance. [electronic resource] by
- Zhang, Jie
- Sridhar, Gayathri
- Barr, Charles E
- Eichelberger, Bernadette
- Lockhart, Catherine M
- Marshall, James
- Clewell, Jerry
- Accortt, Neil A
- Curtis, Jeffrey R
- Holmes, Cynthia
- McMahill-Walraven, Cheryl N
- Brown, Jeffrey S
- Haynes, Kevin
Producer: 20210107
In:
Journal of managed care & specialty pharmacy vol. 26
Availability: No items available.
|
|
13.
|
Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims. [electronic resource] by
- Zhang, Jie
- Haynes, Kevin
- Mendelsohn, Aaron B
- Marshall, James
- Barr, Charles E
- McDermott, Cara
- Brown, Jeffrey
- Kline, Annemarie
- Kenney, James
- King, Katelyn J
- Holmes, Cynthia
- Yeung, Kai
- Barron, John
- Yun, Huifeng
- Lockhart, Catherine M
Producer: 20210426
In:
Pharmacoepidemiology and drug safety vol. 29
Availability: No items available.
|